Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions (PCI) (ISAR-REACT-3)

Clinical Trial ID NCT00262054

Rank	Title	Journal	Year	PubWeight™‹?›
1	Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.	Eur Heart J	2005	6.86
2	Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial.	JAMA	2003	4.74
3	A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.	N Engl J Med	2004	3.07
4	Bivalirudin vs. unfractionated heparin during percutaneous coronary interventions in patients with stable and unstable angina pectoris: 1-year results of the ISAR-REACT 3 trial.	Eur Heart J	2010	1.55
5	Bivalirudin versus unfractionated heparin during percutaneous coronary intervention.	N Engl J Med	2008	1.37
6	Direct thrombin inhibitors: appraisal of the antithrombotic/hemorrhagic balance.	Thromb Haemost	1997	0.78